
Medicine and Health
Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies
K. Challa, D. Paysan, et al.
This groundbreaking study explores chromatin organization in PBMCs as game-changing biomarkers for cancer diagnosis and treatment evaluation. Authored by Kiran Challa, Daniel Paysan, Dominic Leiser, Nadia Sauder, Damien C. Weber, and G. V. Shivashankar, the research showcases a highly accurate machine learning pipeline capable of distinguishing healthy individuals from tumor patients and evaluating treatment effects. Discover the future of cancer diagnostics!
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.